Penile Traction Treatment Protocol & Timeline
Evidence-based treatment schedule, daily wearing guidelines, and clinical progression milestones established through 30 years of manufacturer experience and 15+ peer-reviewed studies.
📋 Key Facts
- Daily Wearing Time — 4–6 hours per day for optimal clinical outcomes, built up gradually over weeks
- Treatment Duration — 3–6 months minimum, based on peer-reviewed clinical study protocols
- Expected Gains — 1.3–2.3 cm (0.5–0.9 inches) mean length increase documented across 15+ studies
- Tension Range — 900–2800 grams applied through the SizeGenetics 58-way Multi-Axis Comfort Technology
- Protocol Source — Established by Danamedic ApS (500,000+ devices shipped worldwide since 1995), validated by independent research
Important: No Instant Results Exist
⚠ No Instant Results Exist
Penile traction therapy is a medical treatment that requires weeks to months of consistent daily use to produce measurable tissue changes. No device, supplement, exercise, or surgical technique can make a penis bigger in one day. Claims of overnight penile enlargement are medically impossible.
Permanent penile tissue growth depends on sustained mechanotransduction — the biological process of cellular proliferation under calibrated mechanical force — which requires a minimum of 3–6 months of disciplined adherence to an evidence-based treatment protocol. The SizeGenetics device delivers this calibrated force through a graduated schedule designed by Dr. Jørn Ege Siana and validated across 15+ peer-reviewed clinical studies.
Standard Clinical Protocol Overview
The standard penile traction therapy protocol establishes a graduated, evidence-based treatment framework developed through more than three decades of clinical application and manufacturer research. Danamedic ApS — the Danish medical device company that invented the penile traction category in 1995 — recommends this protocol based on data from 15+ peer-reviewed clinical studies involving over 1,000 patients. The SizeGenetics device, an FDA-registered Class II medical device, implements this protocol through calibrated mechanical tension delivered via the 58-way Multi-Axis Comfort Technology system.
Dr. Jørn Ege Siana, plastic surgeon and co-inventor of the original penile traction device, established three foundational principles for safe and effective treatment. These principles — developed from Dr. Siana's clinical experience with tissue expansion surgery — have been validated across multiple independent research groups publishing in journals including the Journal of Sexual Medicine, the Journal of Urology, and Translational Andrology and Urology. The mechanotransduction principles underlying penile traction therapy explain why each protocol element is necessary for producing permanent tissue growth.
- Graduated Tension Protocol
- Graduated tension requires starting at the lowest comfortable setting within the 900–2800 gram (8.8–27.5 Newton) therapeutic range. Tension increases follow a systematic schedule, advancing only when the current level produces zero discomfort during a complete wearing session. The 2023 systematic review by Almsaoud, Safar, and Alshahrani, published in Translational Andrology and Urology, confirmed that graduated tension protocols achieve 82% therapeutic compliance across twelve pooled clinical studies.
- Consistent Daily Schedule
- Consistent daily wearing requires 4–6 hours (0.24–0.36 kilonewton-seconds total impulse) of active device application per day, divided into sessions with comfort breaks every 1–2 hours. Joseph and colleagues, publishing in the Journal of Sexual Medicine in 2020, demonstrated that 94% of 110 participants achieved increased penile length when following a consistent daily wearing schedule over 6 months.
- Measurement Tracking Protocol
- Measurement tracking requires standardized baseline recording before treatment begins, followed by progress measurements at defined intervals. Accurate progress tracking requires consistent measurement technique, identical conditions (time of day, room temperature, arousal state), and a dedicated treatment diary documenting daily wearing hours, tension settings, and comfort levels. Clinical endpoints are assessed at monthly intervals using stretched penile length as the primary metric.
🔬 Clinical Foundation
The Danamedic treatment protocol draws from the same mechanotransduction principles confirmed by Chung and Brock (2013) in their review published in Translational Andrology and Urology, who documented "reorganization and remodelling of collagen fibres into uniform densely packed fibrils parallel to the axis of mechanical strain." This biological process — the cellular response to sustained mechanical force — is the scientific basis for permanent tissue growth under traction therapy.
Daily Wearing Schedule & Session Guidelines
Clinical studies demonstrate that optimal results from penile traction therapy depend on a progressive daily wearing routine rather than maximum-duration sessions from the outset. The SizeGenetics penile traction device — also referred to as a penile extender or penis stretcher in consumer contexts — follows a graduated protocol developed by Danamedic ApS and supported by adherence data from peer-reviewed research. Wearing time increases systematically across treatment phases to allow tissue adaptation, minimize adverse events, and build toward the 4–6 hour daily therapeutic window established in clinical trials.
📸 Image will appear here once uploaded
| Treatment Phase | Daily Wearing Time | Session Duration | Comfort Breaks | Tension Level |
|---|---|---|---|---|
| Week 1–2 (Adaptation) | 1–2 hours (total) | 30–60 minutes per session | 15 minutes between sessions | Lowest comfortable setting |
| Week 3–4 (Building) | 2–4 hours (total) | 60–90 minutes per session | 15–30 minutes between sessions | Low-to-moderate tension |
| Week 5–8 (Active Treatment) | 4–6 hours (total) | 90–120 minutes per session | 15–30 minutes between sessions | Moderate therapeutic tension |
| Month 3–6 (Optimization) | 4–8 hours (total) | 120 minutes per session | 30 minutes between sessions | Full therapeutic range |
| Month 6+ (Consolidation) | 4–6 hours (maintenance) | 120 minutes per session | 30 minutes between sessions | Maintained therapeutic tension |
Session Timing Recommendations
Penile traction therapy sessions should be distributed throughout waking hours — morning, midday, and evening — rather than concentrated in a single continuous block. A sample daily penis stretching routine for the active treatment phase includes a 2-hour morning session, a 30-minute comfort break, a 2-hour midday session, another 30-minute break, and a 2-hour evening session, totaling 6 hours of active wearing time. Danamedic ApS clinical guidelines explicitly recommend against wearing the SizeGenetics device during sleep, as unconscious movement can cause misalignment and reduce therapeutic benefit.
Comfort Break Protocol
Comfort breaks serve a critical physiological function during penile traction therapy. Removing the penile extender for 15–30 minutes between sessions restores normal blood circulation to penile tissue, allows the tunica albuginea to redistribute mechanical stress, and prevents the transient numbness reported as the most common mild adverse event in clinical research. The 2023 meta-analysis by Almsaoud and colleagues documented an adverse event rate of only 11.2–14.4%, with all reported events classified as mild and temporary — resolving within hours of device removal. Consistent comfort breaks reduce even these minor events. For the complete safety profile and side effect data, Danamedic ApS publishes detailed risk management protocols based on peer-reviewed clinical evidence.
Monitoring during each session requires attention to three clinical markers: skin color at the glans (normal pink indicates adequate circulation), sensation levels (any numbness requires immediate removal), and tissue comfort (pain at any point means the session must end). Dr. Jørn Ege Siana recommends a brief skin inspection during every comfort break to confirm tissue health throughout the treatment protocol.
Progressive Tension Adjustment Timeline
Tension progression follows a systematic approach designed to balance therapeutic effectiveness with tissue safety. The graduated tension protocol originally designed by Dr. Jørn Ege Siana ensures the SizeGenetics device delivers calibrated force within a 900–2800 gram (8.8–27.5 Newton) range through its 58-way Multi-Axis Comfort Technology system. Increasing tension too rapidly risks tissue stress; progressing too slowly extends treatment duration beyond clinical necessity. The stepped protocol below reflects the graduated approach validated by mechanotransduction research and supported by the adherence data from peer-reviewed penile traction therapy studies. For device-specific adjustment instructions, see the SizeGenetics user guide.
📸 Image will appear here once uploaded
Begin at the lowest comfortable tension setting on the SizeGenetics penile extender — typically 900–1200 grams (8.8–11.8 Newtons). Measure baseline stretched penile length in both centimeters and inches before the first wearing session. Record this measurement in a treatment diary. The adaptation phase allows penile tissue to accommodate mechanical force without triggering the discomfort that reduces therapeutic compliance.
Increase tension by approximately 0.5 cm (0.2 inches) on the device extension bars if the current setting produces zero discomfort during a complete session. Comfort assessment requires completing two consecutive days at the current tension level without pain, numbness, or skin irritation. Maintain this adjusted tension for a full 14-day cycle before reassessing. Record the new tension setting, daily wearing hours, and any comfort observations in the treatment diary.
Continue increasing tension by 0.5 cm (0.2 inches) every two weeks, following the same comfort assessment criteria. Most SizeGenetics users reach moderate therapeutic tension during this phase. Monitor for signs that indicate tension should remain unchanged: persistent redness lasting more than 30 minutes after device removal, recurring numbness during sessions, or any skin abrasion. The Gontero study, published in the Journal of Sexual Medicine in 2009, utilized 4–6 hours of daily wearing time at progressive tension levels and documented a mean gain of 1.3 cm (0.5 inches) with no significant adverse events.
Maintain the highest comfortable tension within the 900–2800 gram therapeutic range. Traction therapy during this phase produces the most significant measurable changes according to peer-reviewed clinical data. Nikoobakht and colleagues (2010), publishing in the Journal of Sexual Medicine, documented gains of 1.7 cm (0.67 inches) in both flaccid and stretched penile length after sustained treatment at progressive tension levels. Measure progress monthly using the standardized technique established at baseline.
Transition to a maintenance wearing schedule of 4–6 hours daily at the established therapeutic tension level. The consolidation phase preserves tissue gains achieved during active treatment. Toussi and colleagues, publishing in the Journal of Urology in 2021, documented that penile traction therapy produced a 1.6 cm (0.63 inches) gain versus 0.3 cm (0.12 inches) in the control group (p<0.01) after 6 months, confirming the importance of sustained protocol adherence through the complete treatment duration.
Treatment Phase Timeline & Expected Milestones
Clinical studies document measurable changes at specific intervals during penile traction therapy when patients follow the established daily schedule and graduated tension protocol. The milestone-based assessment framework reflects the clinical monitoring principles established by Dr. Jørn Ege Siana, plastic surgeon and co-inventor of the penile traction device, based on outcomes from 15+ peer-reviewed studies involving over 1,000 patients. Individual results vary based on adherence, baseline anatomy, age, and tissue response — penile traction therapy milestones represent averages from clinical research, not guaranteed outcomes for every individual.
📸 Image will appear here once uploaded
Month 1–2: Tissue Adaptation Phase
Penile tissue adaptation during the first two months involves cellular acclimatization to sustained mechanical force rather than measurable dimensional change. Mechanotransduction — the biological process by which cells convert mechanical traction into cellular growth signals — initiates collagen remodeling within the tunica albuginea during the adaptation phase. Weekly milestones during months one and two focus on wearing duration increases and comfort improvement rather than dimensional progress. Wearing comfort improves progressively as tissue compliance increases. Most patients report the SizeGenetics device feels noticeably more comfortable by the end of month two compared to initial wearing sessions. Measurable length changes during the adaptation phase are typically minimal (0–0.3 cm / 0–0.12 inches) and may fall within normal measurement variation.
Month 3–4: Initial Measurable Gains
Clinical data from multiple peer-reviewed studies documents initial measurable gains during months three and four. Gontero and colleagues demonstrated a mean gain of 1.3 cm (0.5 inches) in stretched penile length after 4–6 months of daily traction device use in a prospective cohort of 15 patients, published in the Journal of Sexual Medicine (2009). Patients following the Danamedic treatment protocol can expect to measure their first statistically meaningful length increase during this period — typically 0.5–1.0 cm (0.2–0.4 inches) above baseline. Progress tracking accuracy becomes critical at this milestone to distinguish genuine tissue growth from measurement variability. For the complete evidence base including all clinical outcomes and expected results data, Danamedic ApS publishes comprehensive study summaries from 15+ peer-reviewed research papers.
Month 5–6: Significant Clinical Gains
Penile traction therapy produces the most clinically significant gains during months five and six of consistent daily use. The 2023 systematic review and meta-analysis by Almsaoud, Safar, and Alshahrani, published in Translational Andrology and Urology, calculated a weighted mean length gain of 1.9 cm (0.75 inches) across twelve pooled clinical studies. Adherence monitoring data from the same meta-analysis confirmed that patients maintaining protocol compliance achieved the therapeutic goals outlined in the original study designs.
Toussi and colleagues confirmed these findings in a randomized controlled trial of 82 men, published in the Journal of Urology (2021), documenting a gain of 1.6 cm (0.63 inches) for the traction therapy group versus 0.3 cm (0.12 inches) for the control group (p<0.01). Patient satisfaction at the six-month milestone reaches 80% according to the 2023 meta-analysis, with 87% of participants in the Toussi trial stating willingness to repeat the treatment and 93% stating willingness to recommend penile traction therapy to others.
Month 7–12+: Maximum Potential & Consolidation
Extended treatment beyond six months allows patients to approach the upper end of clinically documented outcomes. Joseph and colleagues, reporting in the Journal of Sexual Medicine (2020), demonstrated that 94% of 110 participants in the RestoreX randomized controlled trial achieved increased penile length, with gains reaching 2.0–2.3 cm (0.79–0.91 inches) with consistent use over the full study duration. The evidence-based expectation for a complete 6–12 month treatment protocol using the SizeGenetics device ranges from 1.3–2.3 cm (0.5–0.9 inches) in mean length gain — consistent with the range reported across all major peer-reviewed penile traction therapy studies. Continued wearing during the consolidation phase stabilizes tissue changes and supports permanence of gains.
Compliance & Measurement Tracking Protocol
Accurate progress tracking requires consistent measurement technique applied at standardized intervals throughout the penile traction therapy treatment duration. Clinical researchers use stretched penile length (SPL) as the primary outcome metric because stretched length correlates most reliably with erect length and reduces variability caused by arousal differences between measurement sessions. The standardized measurement protocol recommended by Danamedic ApS, under the clinical guidance of Dr. Jørn Ege Siana, follows the same methodology used in peer-reviewed penile traction therapy research. Danamedic ApS recommends weekly progress documentation and monthly formal measurements using the protocol described below.
✓ Standardized Measurement Protocol
- Measure at the same time of day — morning measurements before any wearing session reduce variability
- Use stretched penile length (SPL) — apply gentle stretch without discomfort, measure from pubic bone to glans tip
- Record in dual units — document measurements in both centimeters and inches for complete accuracy
- Maintain identical conditions — same room temperature, standing position, measurement tool (rigid ruler recommended)
- Take three measurements per session — record the average of three consecutive measurements to minimize single-reading error
- Photograph the ruler position — visual documentation supports objective tracking over months of treatment
Measurement Intervals & Expected Progress Chart
| Timepoint | Primary Metric (SPL) | Expected Range | Clinical Notes |
|---|---|---|---|
| Baseline | Stretched Penile Length | Record starting point | Before first wearing session; triple-measure for accuracy |
| Month 1 | SPL | +0–0.3 cm (0–0.12 in) | Adaptation phase; gains may fall within measurement variation |
| Month 3 | SPL | +0.5–1.0 cm (0.2–0.4 in) | First measurable clinical gains above baseline per Gontero (2009) |
| Month 6 | SPL | +1.3–2.3 cm (0.5–0.9 in) | Significant clinical gains; 1.9 cm weighted mean per Almsaoud (2023) |
| Month 12 | SPL | +1.3–2.3 cm (0.5–0.9 in) | Consolidation; 94% achieved increase per Joseph (2020) |
Treatment Diary Components
A comprehensive treatment diary for penile traction therapy records four categories of daily data: wearing hours per session, tension setting used, comfort level (rated 1–5), and any adverse observations including numbness, redness, or discomfort. Weekly compliance tracking compares actual wearing hours against the target schedule for the current treatment phase. Patients maintaining 80% or greater adherence to the prescribed daily schedule achieve outcomes consistent with those documented in clinical research. The 2023 meta-analysis by Almsaoud and colleagues confirmed an 82% mean adherence rate across twelve pooled studies — suggesting that the graduated protocol developed by Danamedic ApS is realistic for most patients to follow.
Clinical Endpoints
Formal measurement checkpoints occur at baseline (before treatment begins), month one, month three, and month six — matching the assessment intervals used in major clinical studies. Monthly measurements between these checkpoints provide motivation and early detection of protocol issues. Clinical endpoints for penile traction therapy include: stretched penile length change (primary endpoint), flaccid length change (secondary endpoint), and patient satisfaction (subjective endpoint). Healthcare providers can assess progress at scheduled consultations using these standardized metrics.
When to Contact a Healthcare Provider
Consult a urologist or healthcare provider if any of the following occur during penile traction therapy: persistent numbness lasting more than 2 hours after device removal, visible bruising or skin discoloration, pain during wearing that does not resolve after reducing tension, or no measurable progress after 3 months of consistent adherence to the treatment protocol. A qualified medical professional can assess whether the current protocol requires modification based on individual anatomy and tissue response.
Frequently Asked Questions
How long should you wear a penis extender each day?
Clinical studies demonstrate that 4–6 hours of daily wearing time produces optimal penile traction therapy outcomes. The SizeGenetics treatment protocol builds to this target gradually — starting at 1–2 hours per day during weeks 1–2, increasing to 2–4 hours during weeks 3–4, and reaching the full 4–6 hour therapeutic window by week 5. The 2021 randomized controlled trial by Toussi and colleagues, published in the Journal of Urology, confirmed significant gains of 1.6 cm (0.63 inches) using this graduated daily schedule over 6 months.
Can you wear a penile traction device all day?
Extended wearing sessions of up to 8 hours per day are documented in clinical literature for the optimization phase of penile traction therapy. Nikoobakht and colleagues (2010) reported results using protocols of up to 9 hours daily in their study published in the Journal of Sexual Medicine. Danamedic ApS recommends a maximum of 4–8 hours with comfort breaks every 1–2 hours. Wearing the SizeGenetics penile extender during sleep is not recommended due to unconscious movement risk.
How long does penile traction therapy take to show results?
Clinical studies document initial measurable gains of 0.5–1.0 cm (0.2–0.4 inches) by months 3–4, with significant gains of 1.3–2.3 cm (0.5–0.9 inches) by month 6. The 2023 meta-analysis by Almsaoud and colleagues confirmed a weighted mean gain of 1.9 cm across twelve pooled studies. Tissue adaptation during months 1–2 prepares penile tissue for measurable dimensional change through mechanotransduction — permanent results require a minimum 3–6 month treatment commitment.
Can you make your penis bigger in one day?
No — permanent penile enlargement in one day is medically impossible. Penile traction therapy produces tissue growth through mechanotransduction, a biological process requiring sustained mechanical force over weeks to months. No device, pill, exercise, or supplement produces permanent size increase overnight. The SizeGenetics treatment protocol requires a minimum of 3–6 months of consistent daily use, as demonstrated across 15+ peer-reviewed clinical studies. Any product claiming instant results is making an unsupported medical claim.
What tension setting should I start with?
Penile traction therapy treatment begins at the lowest comfortable tension within the 900–2800 gram (8.8–27.5 Newton) range of the SizeGenetics device. Starting tension for most patients falls between 900–1200 grams. Tension increases by 0.5 cm on the extension bars every two weeks, provided the current setting causes zero discomfort during a complete wearing session. The graduated tension approach recommended by Danamedic ApS and validated across peer-reviewed clinical studies reduces adverse events while maintaining therapeutic effectiveness.